Can a Diaphragm-Sensing ventilator mode reduce breathing asynchrony?

NCT ID NCT01426178

First seen Aug 05, 2026 · Last updated Aug 06, 2026 · Updated 1 time

Summary

This trial compares two modes of noninvasive ventilation in adults with acute respiratory failure: standard pressure support (PSV) and a newer mode called Neurally Adjusted Ventilatory Assist (NAVA). NAVA uses electrical signals from the diaphragm to trigger breathing support, which may better match the patient's own breathing efforts. The main goal is to see if NAVA reduces the rate of breathing asynchrony—when the ventilator and the patient are out of sync—compared to PSV. Participants are randomly assigned to receive NAVA first or PSV first, and the study also tracks oxygenation and patient comfort.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
Neurally Adjusted Ventilatory Assist (NAVA) delivered via a specialized catheter
What this could lead to
If NAVA reduces breathing asynchrony, it could improve comfort and oxygenation for patients needing noninvasive ventilation.
What could go wrong
This is a small early-phase trial, so results may not apply broadly. NAVA requires a specialized catheter, which may not be widely available or comfortable for all patients.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ACUTE RESPIRATORY FAILURE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • CHU Clermont-Ferrand

    Clermont-Ferrand, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.